Followers

0
0
0
0
.
6
6
6
6
-0.40 (-0.60%)

As on 27 Jan, 2026 | 14:18

Open Trading A/c
Day Range
65.70
70.99
LH
52 Week Range
65.70
128.74
LH
Volume
* i
Bid / Ask
2,937.00
66.00 / 29.00

Bal Pharma Announcements

We are submitting newspaper advertisements of the postal ballot notice issued by the Company on 08.01.2026 and published on 09.01.2026.

12 Jan, 2026 | 04:50pm • Source: BSE

Confirmation as per Regulation 74(5) of SEBI(DP) Regulations, for the quarter ended 31.12.2025.

09 Jan, 2026 | 12:18pm • Source: BSE

Postal Ballot notice for appointment of Dr.Mukesh Beekamchand ( DIN # 11295580) as independent Director of the Company.

08 Jan, 2026 | 03:59pm • Source: BSE

Trading Window Closure from 1st January 2026 to 16th February 2026- for announcing unaudited financial results for the quarter ended 31.12.2025.

23 Dec, 2025 | 12:49pm • Source: BSE

We are submitting to the exchanges, news paper advertisements of the unaudited standalone and consolidated financial results of the company for the quarter ended 30.09.2029...

17 Nov, 2025 | 04:17pm • Source: BSE

Unaudited standalone and Consolidated financial results for the quarter ended 30.09.2025.

12 Nov, 2025 | 06:56pm • Source: BSE

Board of Directors of the Company has inter alia 1. Approved the unaudited standalone and consolidate financial results for the quarter ended 30.09.2025. 2. Appointed...

12 Nov, 2025 | 06:49pm • Source: BSE

Clarification on the outcome of the board meeting held on 11.08.2025.

07 Nov, 2025 | 03:00pm • Source: BSE

Bal Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/11/2025 ,inter alia, to consider and...

04 Nov, 2025 | 04:44pm • Source: BSE

Compliance Certificate for the quarter ended 30.09.2025, as per SEBI(PIT) Regulations,2015

24 Oct, 2025 | 12:28pm • Source: NSE

Confirmation as per Regulation 74(5) of SEBI(DP) Regulations for the quarter ended 30.09.2025.

06 Oct, 2025 | 12:11pm • Source: BSE

Completion of term of Mr.H.S Venkatesh ( DIN # 01776040) as Independent Director of the Company.

30 Sep, 2025 | 03:12pm • Source: BSE

Trading Window on dealing with the securities of the Company will be closed from 1st October 2025 until 48 hours of announcement of Unaudited financial...

26 Sep, 2025 | 04:18pm • Source: BSE

Outcome of the 38th Annual General Meeting of the Company.

25 Sep, 2025 | 03:41pm • Source: BSE

Newpaper Publication for Notice for the 38th Annual General Meeting of the Company together with e-voting and Book closure .

03 Sep, 2025 | 04:13pm • Source: BSE

We are submitting the Copy of the unabridged Annual Report, for the financial year ended 31.03.2025.

02 Sep, 2025 | 03:26pm • Source: BSE

Newpaper Publication of the Unaudited financial results for the quarter ended 30.06.2025.

13 Aug, 2025 | 05:00pm • Source: BSE

The Board of Directors at their meeting held on 11.08.2025 has fixed 18th September 2025 as record date for the payment of dividend for the...

12 Aug, 2025 | 05:38pm • Source: BSE

Unaudited financial results ( Standalone and consolidated ) for the quarter ended 30.06.2025.

11 Aug, 2025 | 06:09pm • Source: BSE

Board of Directors of the Company has met today and inter alia transacted the following business,1. Approved the unaudited financial results ( standalone and consolidated...

11 Aug, 2025 | 06:04pm • Source: BSE